The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 14,310,562 | 463,125 | SH | SOLE | 0 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 30,294,000 | 935,000 | SH | SOLE | 0 | 0 | 0 | ||
| ALECTOR INC | COM | 014442107 | 11,695,182 | 811,039 | SH | SOLE | 0 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 48,252,000 | 600,000 | SH | SOLE | 0 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 24,157,400 | 860,000 | SH | SOLE | 0 | 0 | 0 | ||
| BIOLIFE SOLUTIONS INC | COM | 09062W204 | 40,374,993 | 2,428,571 | SH | SOLE | 0 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 56,239,750 | 612,500 | SH | SOLE | 0 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 69,061,800 | 940,000 | SH | SOLE | 0 | 0 | 0 | ||
| CAREDX INC | COM | 14167L103 | 22,610,000 | 1,000,000 | SH | SOLE | 0 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 69,586,892 | 5,073,780 | SH | SOLE | 0 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 9,844,782 | 1,523,960 | SH | SOLE | 0 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 3,394,000 | 100,000 | SH | SOLE | 0 | 0 | 0 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 9,958,000 | 650,000 | SH | SOLE | 0 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 9,437,100 | 415,000 | SH | SOLE | 0 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 39,601,500 | 2,550,000 | SH | SOLE | 0 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 5,606,052 | 844,285 | SH | SOLE | 0 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 20,391,900 | 3,365,000 | SH | SOLE | 0 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 14,556,000 | 300,000 | SH | SOLE | 0 | 0 | 0 | ||
| GRITSTONE ONCOLOGY INC | COM | 39868T105 | 15,283,950 | 1,770,000 | SH | SOLE | 0 | 0 | 0 | ||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 14,842,000 | 820,000 | SH | SOLE | 0 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 18,253,200 | 60,000 | SH | SOLE | 0 | 0 | 0 | ||
| INVITAE CORP | COM | 46185L103 | 73,965,737 | 3,838,388 | SH | SOLE | 0 | 0 | 0 | ||
| MAGENTA THERAPEUTICS INC | COM | 55910K108 | 31,273,721 | 3,048,121 | SH | SOLE | 0 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 58,147,250 | 1,115,000 | SH | SOLE | 0 | 0 | 0 | ||
| ORCHARD THERAPEUTICS PLC | ADR | 68570P101 | 3,682,800 | 310,000 | SH | SOLE | 0 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 56,116,000 | 400,000 | SH | SOLE | 0 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 13,167,750 | 1,455,000 | SH | SOLE | 0 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 66,281,600 | 880,000 | SH | SOLE | 0 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 83,722,834 | 863,300 | SH | SOLE | 0 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 2,793,700 | 130,000 | SH | SOLE | 0 | 0 | 0 | ||
| TURNING POINT THERAPEUTICS I | COM | 90041T108 | 2,820,000 | 75,000 | SH | SOLE | 0 | 0 | 0 | ||
| TWIST BIOSCIENCE CORP | COM | 90184D100 | 7,164,000 | 300,000 | SH | SOLE | 0 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 19,414,171 | 1,128,075 | SH | SOLE | 0 | 0 | 0 | ||